{"id":"W2055922098","doi":"10.1158/1538-7445.am2011-4718","title":"Abstract 4718: A randomized phase 2 study of the cyclin-dependent kinase (CDK) inhibitor dinaciclib (SCH 727965) in patients with advanced breast cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Capecitabine; Medicine; Internal medicine; Taxane; Anthracycline; Clinical endpoint; Febrile neutropenia; Neutropenia; Oncology; Breast cancer; Cancer; Chemotherapy; Randomized controlled trial; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001123777,0.0003590912,0.001028716,0.0003729858,0.0001646104,0.00001990746,0.0004944126,0.0001085193,0.001164335],"category_scores_gemma":[0.0001640924,0.0002164411,0.000143155,0.0010674,0.0007035382,0.0002936816,0.000220089,0.001048369,0.000009004763],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007902361,"about_ca_system_score_gemma":0.0007026792,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004741576,"about_ca_topic_score_gemma":0.001859384,"domain_scores_codex":[0.9955237,0.0004349161,0.000745869,0.0007178161,0.001748835,0.0008288755],"domain_scores_gemma":[0.997192,0.0002343402,0.0003172588,0.0009737439,0.001016858,0.0002657628],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5912575,0.009855495,0.3109728,0.0003376775,0.0005505556,0.00008781201,0.007851465,0.0001057653,0.009817908,0.00002863735,0.00005481493,0.06907954],"study_design_scores_gemma":[0.4483905,0.00135782,0.5297429,0.001241008,0.0001282938,0.000005433564,0.002756991,0.000009046897,0.01585115,0.0001004963,0.0001023055,0.0003140949],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922856,0.0009566732,0.000006282345,0.000289579,0.000276097,0.005570685,0.0001655729,0.00003865527,0.0004108507],"genre_scores_gemma":[0.9968253,0.0001534752,0.00007044991,0.00007434295,0.0001643509,0.002353672,0.000006335496,0.00009353253,0.0002585489],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2187701,"threshold_uncertainty_score":0.9997487,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04744629479669468,"score_gpt":0.3890347226297202,"score_spread":0.3415884278330256,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}